Enliven Therapeutics

ELVNNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$3.581 B

$48.87 -1.17%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

-$103.7M

Loss-making

Shares outstanding

73,270,761

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#69Legend BiotechLEGN$3.60B
#70Organon & Co.OGN$3.59B
#71Enliven TherapeuticsELVN$3.58B
#72Viking TherapeuticsVKTX$3.51B
#73Arcus BiosciencesRCUS$3.30B

What if Enliven Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.3T

$413,180.56

Per share 8,455× higher

Bitcoin $1.72T

$23,471.90

Per share 480× higher

Nvidia $5.48T

$74,789.15

Per share 1,530× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Enliven Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.